These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 14696584)

  • 1. Analysis of recent papers in hypertension. Post menopausal hormone replacement therapy prevents diabetes.
    Basile J
    J Clin Hypertens (Greenwich); 2003; 5(5):353-4. PubMed ID: 14696584
    [No Abstract]   [Full Text] [Related]  

  • 2. Lessons from hormone replacement therapy trials for primary prevention of cardiovascular disease.
    Mohandas B; Mehta JL
    Curr Opin Cardiol; 2007 Sep; 22(5):434-42. PubMed ID: 17762545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health system responses to the Women's Health Initiative findings on estrogen and progestin: organizational response.
    Hartsfield CL; Connelly MT; Newton KM; Andrade SE; Wei F; Buist DS
    J Natl Cancer Inst Monogr; 2005; (35):113-5. PubMed ID: 16287896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From the challenge to the reassessment of the Women's Health Initiative: a personal initiative for women's health.
    Gambacciani M; Genazzani AR
    Gynecol Endocrinol; 2006 Mar; 22(3):115-6. PubMed ID: 16835071
    [No Abstract]   [Full Text] [Related]  

  • 5. [Development of menopause management and menopausal related hormone replacement therapy].
    Yu Q
    Zhonghua Fu Chan Ke Za Zhi; 2013 Apr; 48(4):287-90. PubMed ID: 23902813
    [No Abstract]   [Full Text] [Related]  

  • 6. Invited Commentary: Hormone therapy risks and benefits--The Women's Health Initiative findings and the postmenopausal estrogen timing hypothesis.
    Banks E; Canfell K
    Am J Epidemiol; 2009 Jul; 170(1):24-8. PubMed ID: 19468078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hormones and cardiovascular health in women.
    ESHRE Capri Workshop Group
    Hum Reprod Update; 2006; 12(5):483-97. PubMed ID: 16807276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative review of the risks and benefits of hormone replacement therapy regimens.
    Warren MP
    Am J Obstet Gynecol; 2004 Apr; 190(4):1141-67. PubMed ID: 15118656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Should hormone replacement therapy for menopause be continued in diabetic women?].
    Skurnik G; Touraine P
    Journ Annu Diabetol Hotel Dieu; 2004; ():151-60. PubMed ID: 15259313
    [No Abstract]   [Full Text] [Related]  

  • 10. Use of menopausal hormones in the United States, 1992 through June, 2003.
    Wysowski DK; Governale LA
    Pharmacoepidemiol Drug Saf; 2005 Mar; 14(3):171-6. PubMed ID: 15386701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [HRT in 2006].
    Skalba P
    Endokrynol Pol; 2005; 56(6):952-5. PubMed ID: 16821217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-menopausal hormone replacement therapy (cont'd): risk-benefit balance in the hot seat.
    Prescrire Int; 2004 Jun; 13(71):106-9. PubMed ID: 15233153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Menopause, hormone therapy and diabetes.
    Stuenkel CA
    Climacteric; 2017 Feb; 20(1):11-21. PubMed ID: 28064520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in use of hormone replacement therapy after the report from the Women's Health Initiative: cross sectional survey of users.
    Lawton B; Rose S; McLeod D; Dowell A
    BMJ; 2003 Oct; 327(7419):845-6. PubMed ID: 14551101
    [No Abstract]   [Full Text] [Related]  

  • 15. [Risk factor of coronary artery disease in women].
    Kaaja R
    Duodecim; 2003; 119(24):2436-43. PubMed ID: 14870505
    [No Abstract]   [Full Text] [Related]  

  • 16. Prognostic value of coronary artery calcium screening in subjects with and without diabetes.
    Raggi P; Shaw LJ; Berman DS; Callister TQ
    J Am Coll Cardiol; 2004 May; 43(9):1663-9. PubMed ID: 15120828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen plus progestin, benefits and risks: the "Women's Health Initiative" trials.
    Keller KB; Lemberg L
    Am J Crit Care; 2005 Mar; 14(2):157-60. PubMed ID: 15728959
    [No Abstract]   [Full Text] [Related]  

  • 18. Osteoporosis and cardiovascular disease: benefit-risk of hormone replacement therapy.
    Sammartino A; Cirillo D; Mandato VD; Di Carlo C; Nappi C
    J Endocrinol Invest; 2005; 28(10 Suppl):80-4. PubMed ID: 16550729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patterns of hormone replacement therapy in a population-based cohort of postmenopausal German women. Changes after HERS II and WHI.
    Clanget C; Hinke V; Lange S; Fricke R; Botko R; Pfeilschifter J
    Exp Clin Endocrinol Diabetes; 2005 Oct; 113(9):529-33. PubMed ID: 16235155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular risk in women with non-specific chest pain (from the Women's Health Initiative Hormone Trials).
    Robinson JG; Wallace R; Limacher M; Ren H; Cochrane B; Wassertheil-Smoller S; Ockene JK; Blanchette PL; Ko MG
    Am J Cardiol; 2008 Sep; 102(6):693-9. PubMed ID: 18773990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.